4421/6945US=60 / Cab/Pesc
Genden EM, Brett EM. Carcinoma of the thyroid. In: Genden EM, Varvares MA. Head and neck cancer: an evidence-based team approach. New York: Thieme, 2008. p. 90-104. ISBN 978-1-58890-508-6.

CARCINOMA DE TIREOIDE; CANCER DE TIREOIDE; ESTUDO DE CASO


4422/6945US=60 / Cab/Pesc
Wax MK, Gross ND, Andersen PE. Carcinoma of the salivary glands. In: Genden EM, Varvares MA. Head and neck cancer: an evidence-based team approach. New York: Thieme, 2008. p. 105-17. ISBN 978-1-58890-508-6.

CARCINOMA DAS GLANDULAS SALIVARES; CANCER DAS GLANDULAS SALIVARES; ESTUDO DE CASO


4423/6945US=60 / Cab/Pesc
Chaboki H, Wanna GB, Westreich R, Kao J, Packer SH, Lawson W. Carcinoma of the nasal cavity and paranasal sinus. In: Genden EM, Varvares MA. Head and neck cancer: an evidence-based team approach. New York: Thieme, 2008. p. 118-36. ISBN 978-1-58890-508-6.

CARCINOMA DA CAVIDADE NASAL; CARCINOMA DOS SEIOS PARANASAIS; CANCER DA CAVIDADE NASAL; CANCER DOS SEIOS PARANASAIS; ESTUDO DE CASO


4424/6945US=60 / Cab/Pesc
Wei WI, Sham JST. Carcinoma of the nasopharynx. In: Genden EM, Varvares MA. Head and neck cancer: an evidence-based team approach. New York: Thieme, 2008. p. 137-51. ISBN 978-1-58890-508-6.

CARCINOMA DA NASOFARINGE; CANCER DA NASOFARINGE; ESTUDO DE CASO


4425/6945US=60 / Cab/Pesc
Moore BA, Rosenthal D, Kies MS, Weber RS. Carcinoma of the skin of the head, face, and neck. In: Genden EM, Varvares MA. Head and neck cancer: an evidence-based team approach. New York: Thieme, 2008. p. 152-79. ISBN 978-1-58890-508-6.

CARCINOMA DA PELE DA CABECA; CARCINOMA DA PELE DA FACE; CARCINOMA DA PELE DO PESCOCO; ESTUDO DE CASO


4426/6945US=60 / Cab/Pesc
Genden EM, Kao J, Packer SH, Jacobson AS. Carcinoma of unknown primary site. In: Genden EM, Varvares MA. Head and neck cancer: an evidence-based team approach. New York: Thieme, 2008. p. 180-97. ISBN 978-1-58890-508-6.

CARCINOMA DE SITIO PRIMARIO DESCONHECIDO; ESTUDO DE CASO


4427/6945US=60 / Cab/Pesc
Som PM, Genden EM. Surveillance of the patient. In: Genden EM, Varvares MA. Head and neck cancer: an evidence-based team approach. New York: Thieme, 2008. p. 198-203. ISBN 978-1-58890-508-6.

VIGILANCIA DO PACIENTE; PROTOCOLOS; PROGRAMA DE VIGILANCIA; ESTUDO DE CASO


4428/6945US=64 / Câncer
Chng WJ, Bergsagel PL. Biology-based classification and staging of multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 41-56. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

BIOLOGIA BASEADA EM MIELOMA MULTIPLO; ESTADIAMENTO DO MIELOMA MULTIPLO


4429/6945US=64 / Câncer
Braggio E, Sebag M, Fonseca R. Cytogenetic abnormalities in multiple myeloma: the importance of FISH and cytogenetics. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 57-76. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

ANOMALIAS CITOGENETICAS EM MIELOMA MULTIPLO


4430/6945US=64 / Câncer
Badros A. Thalidomide in patients with relapsed multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 205-27. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

TALIDOMIDA EM PACIENTES MIELOMA MULTIPLO; TALIDOMIDA E MIELOMA


4431/6945US=64 / Câncer
Yhomas SK, Richards TA, Weber DM. Lenalidomide in relapsed or refractory multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 265-77. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

LENALIDOMIDA EM RECIDIVA; MIELOMA MULTIPLO REFRACTARIO; ESTEROIDES; ANTRACICLINAS


4432/6945US=64 / Câncer
Frost P, Lichtenstein A. The mammalian target of rapamycin and multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 323-30. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

RAPAMICINA EM MAMIFEROS; MIELOMA MULTIPLO; CELULAS EUCARIOTICAS; IMUNO-HISTOQUIMICA


4433/6945US=64 / Câncer
Mollinedo F. Death receptors in multiple myeloma and therapeutic opportunities. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 393-419. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

RECEPTORES DE MORTE EM MIELOMA MULTIPLO; MIELOMA MULTIPLO


4434/6945US=64 / Câncer
Chauhan D, Singh A, Anderson K. Proteasome inhibitors as therapy in multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 421-32. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

TERAPIA EM MIELOMA MULTIPLO. INIBIDORES DE PROTEASSOMA; HOMEOSTASE CELULAR NORMAL; AGENTES ANTICANCERIGENOS. INIBIDORES DE PROTEASSOMA


4435/6945US=64 / Câncer
Sloan MJ, Raje N. Anemia and erythropoietic growth factors in multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 455-68. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

ANEMIA; ERITROPOIESE EM MIELOMA MULTIPLO. FATORES DE CRESCIMENTO


4436/6945US=64 / Câncer
Durie BGM. The role of anatomic and functional imaging in myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 491-8. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

PAPEL DA IMAGEM ANATOMICA EM MIELOMA; PAPEL DA IMAGEM FUNCIONAL EM MIELOMA


4437/6945US=65 / Biol/Mol
Pennington CJ, Nuttall RK, Sampieri-Ramirez C, Wallard M, Pilgrim S, Edwards DR. Quantitative real-time PCR analysis of degradome gene expression. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 49-65. ISBN 978-0-387-69056-8.

QUANTITATIVO EM TEMPO REAL; ANALISE DE PCR; EXPRESSAO DO GENE DEGRADOME


4438/6945US=65 / Biol/Mol
Prudova A, Keller U, Overall CM. Indentification of protease substrates by mass spectrometry approaches-2. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 83-100. ISBN 978-0-387-69056-8.

SUBSTRATOS DA PROTEAS; ESPECTROMETRIA DE MASSA; ELECTROFORESE BIDIMENSIONAL EM GEL; PROTEOMICA SHOTGUN; PROTEOMICA QUANTITATIVA; ICATS; ITRAQ


4439/6945US=65 / Biol/Mol
Gavrilovic J, Scott X. Unravelling the roles of proteinases in cell migration in vitro and in vivo. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 343-60. ISBN 978-0-387-69056-8.

PROTEINASES; MIGRACAO CELULAR; IN VITRO; IN VIVO; MIGRACAO DE CELULAS DE LEUCOCITOS; AMEBA; INTERACOES DE CELULAS ENDOTELIAIS; INTEGRINAS; MIGRACAO DE CELULAS DE LEUCOCITOS TRANSENDOTELIAIS; MIGRACAO DE CELULAS TUMORAIS EM 2D; MIGRACAO DE CELULAS TUMORAIS EM 3D


4440/6945US=65 / Biol/Mol
Mueller SC, Artym VV, Kelly T. Invadopodia: interface for invasion. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 403-31. ISBN 978-0-387-69056-8.

INVADOPODIA; COMPONENTES MOLECULARES; MEMBRANAS; ATIVIDADE PROTEOLITICA; ACTINA; CORTACTINA; NUCLEOS; PSEUDOPODIA; SALIENCIAS CELULARES EM 3D; INVADOPODIA DEGRADACAO MEDIADA; PROTEASES INVADOPODIAL; MICROAMBIENTE TUMORAL


Primeira | Anterior | Próxima | Última